5-氰基-1,6-二氢-2-甲基-6-氧代-3-吡啶羧酸乙酯 | 52600-52-9

• 物质功能分类: 医药中间体 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-氰基-1,6-二氢-2-甲基-6-氧代-3-吡啶羧酸乙酯
• 英文名称: ethyl 3-cyano-6-methyl-2-oxo-1-pyridine-5-carboxylate
• 英文别名: ethyl 5-cyano-6-hydroxy-2-methylnicotinate；ethyl 5-cyano-6-hydroxy-2-methyl-pyridine-3-carboxylate；5-cyano-6-hydroxy-2-methyl-nicotinic acid ethyl ester；5-Cyan-6-hydroxy-2-methyl-nicotinsaeure-aethylester；2-hydroxy-3-cyano-5-ethoxycarbonyl-6-methyl-pyridine；Ethyl 5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinecarboxylate；ethyl 5-cyano-2-methyl-6-oxo-1H-pyridine-3-carboxylate
• CAS: 52600-52-9
• 化学式: C₁₀H₁₀N₂O₃
• 分子量: 206.201
• InChiKey: FCPREFULXHVXGA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  79.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  5-氰基-1,6-二氢-2-甲基-6-氧代-3-吡啶羧酸乙酯 在 氢氧化钾 、 铜 作用下， 以 喹啉 、 乙醇 为溶剂， 反应 7.0h， 生成 3-氰基-6-甲基-2(1H)-吡啶酮
  参考文献：
  名称：

  Synthesis and cardiotonic activity of esters of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecar☐ylic acids. Crystal structure of 2-methyl, 2-t-butyl and 2-phenyl esters

  摘要：

  DOI：

  10.1016/0223-5234(89)90057-3
• 作为产物：
  描述：

  乙酰乙酸乙酯 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 38.17h， 生成 5-氰基-1,6-二氢-2-甲基-6-氧代-3-吡啶羧酸乙酯
  参考文献：
  名称：

  Development of a Multi-Kilogram-Scale Synthesis of AZD1283: A Selective and Reversible Antagonist of the P2Y₁₂ Receptor

  摘要：

  Ethyl 6-chloro-5-cyano-2-methylnicotinate (4) was coupled with 4-piperidinecarboxylic acid (isonipecotic acid) in 81% yield to pyridine acid 10. An amide coupling between 10 and benzylsulfonamide (6) afforded AZD1283 (1) in 79% yield using CDI as coupling reagent. The synthesis has been developed and scaled up to 20 kg batches of 1, supporting preclinical and clinical studies. Development work towards 2-chloropyridine 4 and benzylsulfonamide (6) is included.

  DOI：

  10.1021/op400288v

文献信息

• [EN] MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES MACROCYCLIQUES À LARGE SPECTRE
  申请人：RQX PHARMACEUTICALS INC

  公开号：WO2018149419A1

  公开（公告）日：2018-08-23

  Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

  本文提供了抗菌化合物，其中在某些实施例中，这些化合物具有广谱生物活性。在各种实施例中，这些化合物通过抑制细菌类型1信号肽酶（SpsB）发挥作用，这是细菌中的一种必需蛋白质。还提供了使用所述化合物的药物组合物和治疗方法。
• Pyridone esters as inotropic agents
  申请人：E. I. Du Pont de Nemours & Co.

  公开号：US04657919A1

  公开（公告）日：1987-04-14

  Described are compounds of the formula ##STR1## wherein R is hydrogen, lower alkyl, halo, cyano, hydroxy, amino, lower alkylamino, --CH.sub.2 NH.sub.2, --CH.sub.2 OH or --COOR"; R' is hydrogen, lower cycloalkyl or lower alkyl; R' is lower alkenyl, lower alkynyl, lower cycloalkyl, --(W).sub.n Y wherein W is straight or branched chain lower alkyl or lower alkenyl, n is 0 to 5, and Y is Ar, lower cycloalkyl, lower alkenyl, lower alkynyl, --COOZ wherein Z is lower alkyl, ##STR2## or NAB wherein A and B are, independently, lower alkyl, benzyl or substituted benzyl, and Ar is 2, 3 or 4-pyridyl, pyridazinyl, pyrimidinyl, quinolyl, isoquinolyl, phthalazinyl, quinazolinyl, thiazolyl, phenyl, benzyl, furyl, tetrahydrofuryl or thienyl, unsubstituted or substituted with lower alkyl, lower alkoxy, halo, amino, or --CF.sub.3 ; R"' is --COOR", ##STR3## and X is oxygen or nitrogen; or a pharmaceutically acceptable salt thereof, and their use in the treatment of impaired ventricular myocardial contractility. The compounds exhibit cardiotonic activity.

  描述了公式##STR1##的化合物，其中R是氢、低级烷基、卤素、氰基、羟基、氨基、低级烷基亚胺、--CH.sub.2 NH.sub.2、--CH.sub.2 OH或--COOR"；R'是氢、低级环烷基或低级烷基；R'是低级烯基、低级炔基、低级环烷基、--(W).sub.n Y，其中W是直链或支链低级烷基或低级烯基，n是0到5，Y是Ar、低级环烷基、低级烯基、低级炔基、--COOZ，其中Z是低级烷基、##STR2##或NAB，其中A和B独立地是低级烷基、苄基或取代苄基，Ar是2、3或4-吡啶基、吡啶嗪基、嘧啶基、喹诺酮基、异喹诺酮基、酞嗪基、喹唑啉基、噻唑基、苯基、苄基、呋喃基、四氢呋喃基或噻吩基，未取代或取代有低级烷基、低级烷氧基、卤素、氨基或--CF.sub.3；R"'是--COOR"，##STR3##，X是氧或氮；或其药物可接受的盐，及其在治疗心室心肌收缩力受损中的应用。这些化合物具有强心作用。
• New Pyridine Analogues VII 543
  申请人：Antonsson Thomas

  公开号：US20080176827A1

  公开（公告）日：2008-07-24

  The present invention relates to certain new pyridin analogues of Formula (I) to processes for preparing such compounds, to their utility as P2Y 12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.

  本发明涉及某些新型的吡啶类似物，其化学式为(I)，涉及制备这些化合物的工艺，它们作为P2Y12抑制剂和抗血栓剂等的效用，它们在心血管疾病中作为药物的使用，以及包含它们的药物组合物。
• [EN] 2-AMINO-6-ALKYL SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS P2Y12 INHIBITORS 308<br/>[FR] DÉRIVÉS DE PYRIDINE SUBSTITUÉS PAR 2-AMINO-6-ALKYLE UTILES COMME INHIBITEURS DE P2Y12
  申请人：ASTRAZENECA AB

  公开号：WO2010005385A1

  公开（公告）日：2010-01-14

  The present invention relates to certain new pyridin analogues of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.

  本发明涉及某些新的Formula（I）的吡啶类似物，以及制备这类化合物的方法，它们作为P2Y12抑制剂和抗血栓药物等的用途，它们在心血管疾病中作为药物的用途，以及含有它们的药物组合物。
• New Pyridine Analogues II
  申请人：Brickmann Kay

  公开号：US20070244088A1

  公开（公告）日：2007-10-18

  The present invention relates to certain new pyridin analogues of Formula (I) to processes for preparing such compounds, to their utility in medicine in general and especially as P2Y 12 inhibitors and as anti-thrombotic agents, etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.

  本发明涉及某些新的Formula (I)的吡啶类似物，涉及制备这类化合物的方法，它们在医学上的用途，特别是作为P2Y12受体拮抗剂和抗血栓药物等，它们在心血管疾病中作为药物的用途，以及含有它们的药物组合物。